Performance

DNLI +35.35%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
DNLI	+1.30%	+23.14%	+35.35%	-18.01%	-35.28%	0.76	0.00%

Summary

DNLI at a glance

DNLI returned +35.35% over the past year and -18.01% a year over five years. Its worst drop in that year was -35.28%, smaller than 46% of stocks on Redstone, and its Sharpe ratio of 0.76 beats 64% of stocks on Redstone. It pays no dividends.

Ranking

How DNLI ranks

Current Drawdown

-25.28%

Rolling Volatility

49.41%

Actions

Metrics

Risk Indicators

Alpha27.00%

Beta1.53x

Sharpe0.76

Sortino1.13

Omega1.14

Calmar1.00

Martin2.70

Profile

About DNLI

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases.

Sector: Health Care
Industry: Biological Products, (no Diagnostic Substances)
Market cap: $3.3B
Listed: Dec 2017
Employees: 507
Headquarters: South San Francisco, CA
Website: denalitherapeutics.com

Comparisons

DNLI: Denali Therapeutics Inc.

DNLI at a glance

How DNLI ranks

Current Drawdown

Rolling Volatility

About DNLI

Related comparisons